Story perspectives

Brain Organoids Reveal Key Insights for LIS1 Lissencephaly

10/17/2025

Summary

Story summary

Researchers developed brain organoids from stem cells of LIS1 lissencephaly patients to study the disorder.
The model reveals that LIS1 gene mutations disrupt microtubules, producing irregular cerebral cortex layers.
Proteostasis dysregulation emerges as a key factor in disease severity.
Existing drugs like everolimus may help restore cellular balance.
The study, published in Nature Communications, underscores prospects for personalized therapies based on individual profiles.

1 of 1

Story summary

Researchers developed brain organoids from stem cells of LIS1 lissencephaly patients to study the disorder.
The model reveals that LIS1 gene mutations disrupt microtubules, producing irregular cerebral cortex layers.
Proteostasis dysregulation emerges as a key factor in disease severity.
Existing drugs like everolimus may help restore cellular balance.
The study, published in Nature Communications, underscores prospects for personalized therapies based on individual profiles.